Corcept Therapeutics | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 32.37M 13.08M 2025-06
Alaunos Therapeutics USD -755000 395K 2024-12
ANI Pharmaceuticals USD 15.17M 11.02M 2025-06
Ardelyx USD 8.12M 5.89M 2024-12
Aurora Cannabis CAD 36.22M 38.61M 2024-12
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Canopy Growth CAD -23822000 21.8M 2024-12
Corcept Therapeutics USD 26.67M 23.26M 2025-06
Eli Lilly USD 7.02B 1.61B 2025-06
J&J USD 6.94B 6.69B 2025-06
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Merck USD 6.36B 494M 2025-06
Novartis USD 4.86B 201M 2025-06
Novartis USD 3.4B 193M 2024-12
Pacira USD 10.23M 8.24M 2025-06
Pfizer USD 2.6B 1.06B 2025-06
Supernus Pharmaceuticals USD 12.14M 14.74M 2025-06
TG Therapeutics USD 34.84M 26.22M 2025-06


Corcept Therapeutics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.